Alvotech SA reports results for the quarter - Earnings Summary

• Alvotech SA ALVO.OQ reported a quarterly adjusted loss of 2 cents​​ per share for the quarter , higher than the same quarter last year, when the company reported EPS of -82 cents. The lone analyst forecast for the quarter was for a loss of 6 cents per share.

• Revenue was $102.99 million​; analysts expected $89.00 million.

• Alvotech SA's reported EPS for the quarter was a loss of 2 cents​.

• The company reported a quarterly loss of $11.39 million.

• Alvotech SA shares had risen by 2.2% this quarter and gained 5.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Alvotech SA is 19.50

This summary was machine generated from LSEG data November 14 at 04:13 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)